Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Susanna Clare Hopley Price has worked on the following 18 EPO patent applications which have been published in the last five years:

EP12707343

PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS

IPC classification:
A61K 31/4985, A61P 19/02, A61P 29/00, A61P 35/00, A61P 37/06, C07D 471/04, C07D 519/00
Applicant:
Glaxo Group Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12707342

PYRIDINYL- AND PYRAZINYL-METHYLOXY-ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)

IPC classification:
A61K 31/47, A61P 37/00, C07D 401/12, C07D 403/12
Applicant:
Glaxo Group Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11760360

INDAZOLYL-PYRIMIDINES AS KINASE INHIBITORS

IPC classification:
A01N 43/54, A61K 31/505, A61P 29/00, C07D 403/12, C07D 409/14, C07D 471/04
Applicant:
Glaxo Group Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11760361

PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS

IPC classification:
A01N 43/90, A61K 31/54, A61P 29/00, C07D 401/14, C07D 403/12, C07D 405/14, C07D 409/14, C07D 413/14
Applicant:
Glaxo Group Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13836616

AMINO-QUINOLINES AS KINASE INHIBITORS

IPC classification:
A61K 31/47, C07D 215/42
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13837571

PRODRUGS OF AMINO QUINAZOLINE KINASE INHIBITOR

IPC classification:
A61K 31/535
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13763100

TREATMENT FOR RHEUMATOID ARTHRITIS

IPC classification:
A61K 39/395, A61P 29/00, C07K 16/24
Applicant:
MorphoSys AG
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11763417

IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS

IPC classification:
A01N 43/50, A61K 31/415, C07D 401/14, C07D 403/14, C07D 405/14, C07D 413/14
Applicant:
Glaxo Group Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13798807

THIENO[3,2-C]PYRIDIN-4(5H)-ONES AS BET INHIBITORS

IPC classification:
A61K 31/44, C07D 495/04
Applicant:
GlaxoSmithKline LLC
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
PATENT GRANTED
EP14705891

HETEROCYCLIC AMIDES AS KINASE INHIBITORS

IPC classification:
A61K 31/55, A61P 17/06, A61P 25/28, A61P 29/00, A61P 37/00, C07D 267/14, C07D 281/10, C07D 403/12, C07D 403/14, C07D 409/12, C07D 413/12, C07D 413/14, C07D 417/12, C07D 487/04, C07D 498/04
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14708681

QUINAZOLINES AS KINASE INHIBITORS

IPC classification:
A61K 31/505, C07D 403/12, C07D 405/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
The patent has been granted
EP14713394

2,3-DISUBSTITUTED 1 -ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/4375, A61K 31/4706, A61K 31/4709, C07D 215/227, C07D 215/44, C07D 215/46, C07D 215/48, C07D 401/04, C07D 401/12, C07D 401/14, C07D 405/04, C07D 405/14, C07D 409/12, C07D 409/14, C07D 413/04
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14709932

FUROPYRIDINES AS BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/4355, A61K 31/5025, A61P 29/00, C07D 491/048
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
The patent has been granted
EP15194091

OSTEOARTHRITIS TREATMENT

IPC classification:
A61K 39/395, A61P 19/02, C07K 16/28
Applicant:
University of Melbourne
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP11719781

7-(1H-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS

IPC classification:
A61K 31/4462, A61P 19/02, C07D 471/04
Applicant:
Glaxo Group Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11778419

AMINO-QUINOLINES AS KINASE INHIBITORS

IPC classification:
A61K 31/47, A61P 37/00, C07D 215/44, C07D 401/12, C07D 405/12, C07D 405/14, C07D 411/12, C07D 413/12, C07D 417/12, C07D 417/14
Applicant:
Glaxo Group Limited
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11816959

QUINOLYL AMINES AS KINASE INHIBITORS

IPC classification:
A61K 31/4706, A61P 19/00, C07D 401/12, C07D 405/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16162171

ANTI-GM-CSF ANTIBODIES AND USES THEREFOR

IPC classification:
A61K 39/00, C07K 16/24
Applicant:
MorphoSys AG
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature